A Study of OPD5 Followed by Autologous Stem Cell Transplant for Patients With Relapsed Refractory Multiple Myeloma
Clinical trial NCT04918511 · WITHDRAWN
Trial details
- NCT number
- NCT04918511
- Sponsor
- Oncopeptides AB
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-27
- Primary completion
- 2024-03-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.